Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Indiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Indiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Indiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ghassan Jano (NPI 1831176874)

Field	Value
Entity Type	Individual
Organization	Ghassan Jano
Address	929 Ridge Rd
City	Munster
State	IN
ZIP	46321
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	December 30, 2005

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the sole payer presence on file: lifetime Medicare revenue is $2.1M and there is no Medicaid billing on file. The absence of Medicaid activity makes this effectively a single‑payer (Medicare) practice for the data available, concentrating exposure to Medicare reimbursement and utilization trends.

Revenue is highly concentrated in a very small set of services: the precomputed top three Medicare codes account for 74.4% of this provider’s total Medicare revenue. In particular, J9271 (pembrolizumab) alone represents 63.0% of Medicare revenue, marking a dominant dependency on a single high-cost oncology drug.

The code mix and volumes point to an infusion‑centric hematology/oncology practice: J9271 has 29.3K claims and $1.3M revenue, 96413 shows 1.3K claims and $121.6K revenue for chemotherapy administration, and multiple infusion/add‑on codes (96367, 96365, 96417, 96415) appear in the top codes. High counts for supportive and adjunctive medications such as Q5106 (13.1K claims, epoetin biosimilar) and J2469 (5.2K claims, palonosetron) further indicate frequent infusion sessions with concurrent supportive care.

Competitive standing by code is unusually strong on several national measures: 96413 ranks #22 of 7514 (100th percentile; extreme outlier), 99233 ranks #1229 of 128818 (99th percentile; extreme outlier), and J9271 ranks #132 of 1841 (93th percentile; notably above typical national volume). These rankings indicate the provider is a national high‑volume outlier for core oncology administration and inpatient follow‑up E/M activity, even if overall Medicare revenue is $2.1M.

Ancillary supportive therapies and specialty injectables are prominent and frequently billed: Q5106 (epoetin alfa‑epbx) has 13.1K claims and $78.6K revenue and ranks #9 of 695 (99th percentile; extreme outlier), J1569 (immune globulin) has 2.2K claims and $80.6K revenue, and J3489 (zoledronic acid) and J2930 (methylprednisolone) also appear with very high national ranks. This pattern suggests integrated anemia management, hydration/infusion support and bone health interventions are routine components of the practice’s care mix.

The provider shows significant hospital‑based care activity in addition to outpatient infusions: 99233 (subsequent inpatient E/M) has 1.2K claims and $107.7K revenue, and 99223 (initial inpatient E/M) has 279 claims and $35.2K revenue, both with high national percentiles. High volumes of inpatient E/M combined with outpatient infusion codes imply the provider manages both inpatient oncology visits and ongoing outpatient treatment, reflecting a blended hospital/clinic operating model.

Tenure and sustained billing history are evident: the NPI was enumerated 2005-12-30 (~21 years ago), indicating long‑standing Medicare participation. That longevity, paired with concentrated high volumes in immunotherapy and chemotherapy administration, suggests an established clinical role in oncology care within the Medicare population.

From an operational and payer‑mix perspective, the practice faces concentration sensitivity: reliance on J9271 for 63.0% of Medicare revenue and having the top three codes supply 74.4% of revenue creates exposure to changes in drug utilization, prior authorization, or reimbursement for those specific therapies. Coupled with no Medicaid volume on file, payers and network analysts should note the provider’s dependence on a narrow set of high‑value oncology services when assessing contracting, access, or utilization management strategies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

41 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	29,330	$40	$1.3M
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	1,310	$90	$121.6K
99233	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the…	1,210	$90	$107.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,650	$60	$103.8K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	2,240	$40	$80.6K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	13,100	$10	$78.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	570	$80	$45.5K
99223	The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the…	280	$130	$35.2K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	1,540	$20	$32.3K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	460	$50	$20.7K

Showing 1–10 of 41

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 41 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Indiana Distribution

Ghassan Jano — 18 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Indiana

Full comparison — all codes billed, vs. state median

41 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	3	20	11,200	$40	$631.7K
J1569	1	10	2,240	$40	$79.9K
Q5106	1	10	2,530	$10	$35.3K
96413	2	120	140	$90	$19.1K
99214	795	10,540	110	$80	$15.5K
99233	13	2,720	80	$90	$13.4K
99232	2,516	3,970	90	$60	$11.8K
J9025	2	10	21,450	$1	$10.6K
99223	73	3,080	40	$120	$8.2K
99213	24	10,820	80	$50	$7.6K

Showing 1–10 of 41

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ghassan Jano, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Methodist Hospitals, Inc	IN	General Acute Care Hospital	$0	$75.6M
Community Care Network Inc	IN	Family Medicine Physician	$0	$33.9M
The Methodist Hospitals, Inc	IN	Internal Medicine Physician	$0	$10.9M
Mohamad Kassar	IN	Hematology & Oncology Physician	$4.7M	$0
Suniti Medical Corporation	IN	Specialist	$0	$4.3M
Ramon Lee	IL	Retina Specialist (Ophthalmology) Physician	$4M	$8.5K
Sohail Hasan	IL	Retina Specialist (Ophthalmology) Physician	$3.4M	$34.2K
Neel Shah	IN	Hematology & Oncology Physician	$3.2M	$0
Raja Devanathan	IN	Pulmonary Disease Physician	$3M	$0
Michael Tallarico	IN	Medical Oncology Physician	$2.7M	$0

Nearby Providers

Other providers in the same ZIP code as Ghassan Jano, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Munster Medical Research Foundation Inc	IN	General Acute Care Hospital	$0	$23.6M
Munster Radiology Group PC	IN	Diagnostic Radiology Physician	$0	$6.4M
Preference Health Services Inc.	IN	Home Health Agency	$0	$6.1M
Nwi Urgent Care, LLC	IN	Urgent Care Clinic/Center	$0	$4.4M
Childrens & Family Medicine Clinic PC	IN	Primary Care Clinic/Center	$0	$4.2M
Urgentdent	IN	Dental Clinic/Center	$0	$4M
Chest Physician Consultants, Ltd	IN	Multi-Specialty Clinic/Center	$0	$3.9M
Cep America LLC	IN	Emergency Medicine Physician	$0	$3.5M
Midwest Emergency Associates-munster, LLC	IN	Emergency Medicine Physician	$0	$3.2M
Jeffrey T. Meister, Dds, LLC	IN	General Practice Dentistry	$0	$3M

Ghassan Jano — Billing Profile & Reimbursement Data

Sign up for Ghassan Jano — Billing Profile & Reimbursement Data policy alerts

Ghassan Jano — Billing Profile & Reimbursement Data

Sign up for Ghassan Jano — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References